TITLE

Stem cells: Promise to cure?

AUTHOR(S)
Damle, S. G.
PUB. DATE
April 2012
SOURCE
Contemporary Clinical Dentistry;Apr-Jun2012, Vol. 3 Issue 2, p143
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the importance of stem cell research in curing several medical and dental problems. It is stated that stem cells have the ability to renew themselves through mitotic cell division; and stem cells can also be grown and transformed into specialized cells. Induced Pluripotent Stem Cells (IPS) is a popular method for stem cell research. Stem cell research can bring treatments that would cure diseases including Alzheimer's disease, Parkinson's disease, and heart diseases.
ACCESSION #
99468697

 

Related Articles

  • Induced Pluripotent Stem Cells. Wilson, Kitchener D.; Wu, Joseph C. // JAMA: Journal of the American Medical Association;4/28/2015, Vol. 313 Issue 16, p1613 

    The article discusses the 2006 discovery of a method for creating induced pluripotent stem cells (iPSCs) by Takahashi and Shinya Yamanaka and colleagues, which won Yamanaka a Nobel Prize in 2012. Topics include the use of pluripotency to regenerate human organs and tissues, the time consumption...

  • Isogenic iPSC-derived models of disease. Niemitz, Emily // Nature Genetics;Jan2014, Vol. 46 Issue 1, p7 

    The article informs that researchers including Stuart Lipton and Rudolf Jaenisch found that a MEF2CPGC1α– mediated neuroprotective pathway can be used as a genetic target to develop therapeutic for Parkinson's disease and used using induced pluripotent stem cells (iPSCs) for the research.

  • Back to the future of stem cells.  // New Scientist;5/18/2013, Vol. 218 Issue 2917, p3 

    The article introduces a report within the issue about therapeutic cloning research, focusing on ethical and legal issues related to the use of stem cells and induced pluripotent stem cells (iPS).

  • Embryo-like features of induced pluripotent stem cells defy legal and ethical boundaries. Meskus, Mianna; de Miguel Beriain, Iñigo // Croatian Medical Journal;dec2013, Vol. 54 Issue 6, p589 

    The article discusses emerging ethical aspects in stem cell science following the successes made in reprogramming adult cells to become induced pluripotent stem (IPS) cells in vitro as well as in vivo conditions. Topics discussed include advantages of reprogramming cells in disease modeling and...

  • Pushing the Reset Button: Chemical-Induced Conversion of Amniotic Fluid Stem Cells Into a Pluripotent State. Diecke, Sebastian; Wu, Joseph C // Molecular Therapy;Oct2012, Vol. 20 Issue 10, p1839 

    The authors discuss the study on the factor-free derivation of a pluripotent cell type using a c-Kit+ subpopulation of human amniotic fluid cells. The authors say that the potential of human embryonic stem cells (hESC) to differentiate into any cell type of the human body has raised the hope on...

  • REWIND STEM CELLS, THEN FAST FORWARD. Coghlan, Andy // New Scientist;12/22/2012, Vol. 216 Issue 2896/2897, p21 

    The article discusses the development of a process to transform adult cells into a stem cell state, focusing on induced pluripotent stem cells reverted by the researcher Shinya Yamanaka and a clinical trial planned by the biotechnology company Advanced Cell Technology Inc.

  • Japan stem-cell trial stirs envy. Reardon, Sara; Cyranoski, David // Nature;9/18/2014, Vol. 513 Issue 7518, p287 

    The article discusses the clinical trials of induced pluripotent stem (iPS) cells. It states that the iPS cells are created by using a patient's own tissue and by inserting them in an adult's DNA cells to reprogram the cells to an embryonic-like state. The therapy was pioneered by Shinya...

  • Corrigendum: Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Lister, Ryan; Pelizzola, Mattia; Kida, Yasuyuki S.; Hawkins, R. David; Nery, Joseph R.; Hon, Gary; Antosiewicz-Bourget, Jessica; O'Malley, Ronan; Castanon, Rosa; Klugman, Sarit; Downes, Michael; Yu, Ruth; Stewart, Ron; Ren, Bing; Thomson, James A.; Evans, Ronald M.; Ecker, Joseph R. // Nature;10/2/2014, Vol. 514 Issue 7520, p126 

    A correction to the article "Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cell" that was published in the March 03, 2011 issue is presented

  • Progress on stem cell research towards the treatment of Parkinson's disease. Gibson, Stuart A. J.; Guo-Dong Gao; McDonagh, Katya; Sanbing Shen // Stem Cell Research & Therapy;2012, Vol. 3 Issue 2, p1 

    Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive accumulation of Lewy body inclusions along with selective destruction of dopaminergic (DA) neurons in the nigrostriatal tract of the brain. Genetic studies have revealed much about the pathophysiology of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics